IMGO
IMAGO BIOSCIENCES INC (IMGO)
$35.920.14%▲
Market is closedMarket is closed – opens on 8 PM, 12 Dec 2022
– opens on 8 PM, 12 Dec 2022
Key Stats
$35.85
Day's Range
$35.94
$11.56
52-Week Range
$35.94
| Returns | |
| 1 month return | 114.06% |
| 3 month return | 112.29% |
| 1 year return | 79.6% |
| 5 year return | 120.5% |
Company Information
Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the lead product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (NCT04254978) and myelofibrosis (NCT03136185). Bomedemstat has U.S. FDA Orphan Drug and Fast Track Designation for the treatment of ET and MF, European Medicines Agency (EMA) Orphan Designation for the treatment of ET and MF, and PRIority MEdicines (PRIME) Designation by the EMA for the treatment of MF. The company is based in South San Francisco, California.
| Organization | IMAGO BIOSCIENCES INC |
| Employees | 41 |
| CEO | Dr. Hugh Young Rienhoff Jr., M.D. |
| Industry | Healthcare |
Analyst Recommendation
based on 4 analysts ratings
Buy
100%
Buy
0%
Hold
0%
Sell
Based on 4 Wall street analysts offering stock ratings for IMAGO BIOSCIENCES INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 0.22%Current
$35.92
Target
$36.0
Recommendation Trend
Based on 4 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 4 | 10 | 10 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 1.2B |
| Book Value | $5.11 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -2.16 |
| Wall Street Target Price | 36.0 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 7.0 |
| Enterprise Value | 1.0B |
| Enterprise Value/Revenue | 0.0 |
| Enterprise Value/Ebitda | -16.39 |
Technicals
| 50 Day MA | 21.35 |
| 200 Day MA | 18.05 |
Institutional Holdings
FMR Inc
14.95%
BlackRock Inc
12.59%
Omega Fund Management LLC
8.92%
Citadel Advisors Llc
7.44%
Farallon Capital Management, L.L.C.
7.3%
Blackstone Inc
7.02%
Discover more
Frequently Asked Questions
What is IMAGO BIOSCIENCES INC share price today?
Can Indians buy IMAGO BIOSCIENCES INC shares?
How can I buy IMAGO BIOSCIENCES INC shares from India?
Can Fractional shares of IMAGO BIOSCIENCES INC be purchased?
What are the documents required to start investing in IMAGO BIOSCIENCES INC stocks?
What are today’s High and Low prices of IMAGO BIOSCIENCES INC?
What are today’s traded volumes of IMAGO BIOSCIENCES INC?
What is today’s market capitalisation of IMAGO BIOSCIENCES INC?
What is the 52 Week High and Low Range of IMAGO BIOSCIENCES INC?
How much percentage IMAGO BIOSCIENCES INC is down from its 52 Week High?
How much percentage IMAGO BIOSCIENCES INC is up from its 52 Week low?
What are the historical returns of IMAGO BIOSCIENCES INC?
Who is the Chief Executive Officer (CEO) of IMAGO BIOSCIENCES INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*